In another study, the anti-osteoporosis drug teriparatide, an anabolic drug that promotes bone remodeling in patients with osteoporosis, was found to trigger the secretion of POSTN to promote bone formation and counteract osteoporosis. Here, POSTN is linked to osteoporosis.